The Food and Drug Administration (FDA) is rescinding its recommendations on use of a drug once touted by President Donald Trump to be a “game-changer” in the fight against coronavirus.
Hydroxychloroquine was previously given “emergency use” authorization for patients hoping it could help in the treatment of the disease. That status was removed in an announcement from the agency on Monday.
FDA chief scientist Denise Hinton, writing to Gary Disbrow of the Biomedical Advanced Research and Development Authority, announced that “it is no longer reasonable to believe that oral formulations of HCQ [hydroxychloroquine] and CQ [chloroquine] may be effective in treating COVID-19, nor is it reasonable to believe that the known and potential benefits of these products outweigh their known and potential risks.”
“Accordingly, FDA revokes the EUA for emergency use of HCQ and CQ to treat COVID-19,” Hinton added.
Trump had been touting hydroxychloroquine for months, recommending it without having scientific backing to support his claims on its efficacy.
“I’m seeing people dying without it…. When that’s happening, they should do it. What really do we have to lose?” Trump said in early April.
Evidence for hydroxychloroquine’s use being beneficial, however, was anecdotal, and not based on scientific studies. As more studies came out about the drug, for the most part, they seemed to suggest its use wasn’t a good idea.
One study focusing on VA patients who contracted COVID-19 found that those who were treated with hydroxychloroquine were actually more likely to die compared to those who were treated using conventional measures. Trump dismissed that article published toward the end of April, saying that he hadn’t read it yet. Days later, he continued to peddle the drug.
In the middle of May, Trump doubled down on hydroxychloroquine, telling reporters that he had begun using it weeks prior in a preventative way.
“I take it,” he said. “I hope to not be able to take it soon because, you know, I hope they come up with some answer. But I think people should be allowed to.”
After Trump’s announcement, Michael Ryan, director of the World Health Organization’s Health Emergencies Program, discouraged the use of the drug or its promotion outside of scientific trials looking into its potential for treating coronavirus.
“Every sovereign nation, particularly those with effective regulatory authorities, is in a position to advise its own citizens regarding the use of any drug…. I would point out, however, at this stage, [neither] hydroxychloroquine, nor chloroquine, have been, as yet, found to be as effective in the treatment of COVID-19 or in the prophylaxis against coming down with the disease,” Ryan said then.
According to reporting from Healthline, there are serious side effects in using hydroxychloroquine. For example, use of the the drug can lead to heart disease, including heart failure and arrhythmia, which can sometimes be fatal. Other side effects include vision impairment, which can sometimes become permanent.
We’re not backing down in the face of Trump’s threats.
As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.
Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.
As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.
At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.
Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.
You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.